# US 2019/0376954 A1 · Anastasis biosensor

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2019/0376954 A1
- Document ID: US20190376954A1
- Status: Published application
- Kind: A1
- Application number: 16/248,157
- Filed: 2019-01-15
- Published: 2019-12-12
- Earliest claimed: 2012-03-07
- Assignees: The Johns Hopkins University
- Applicants: The Johns Hopkins University
- Inventors: Denise Montell; Ho Lam Tang
- Web page: https://patentgrep.com/patent/US20190376954A1

## CPC

- G01N 33/5091: {for testing the pathological state of an organism}
- A01K 67/0275: Genetically modified vertebrates, e.g. transgenic
- G01N 33/582: {with fluorescent label}
- G01N 33/6872: {Intracellular protein regulatory factors and their receptors, e.g. including ion channels}
- A01K 2227/105: Murine
- A01K 2267/0393: Animal model comprising a reporter system for screening tests
- G01N 2510/00: Detection of programmed cell death, i.e. apoptosis
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- A01K: ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS

## Abstract

The present invention relates to the field of anastasis, i.e., the process of reversal of apoptosis. More specifically, the present invention provides methods and compositions useful for studying anastasis. In one embodiment, the present invention provides an in vivo biosensor comprising (a) a transcription factor complex comprising the Gal4 transcription factor linked to an enzyme cleavable linker, wherein the transcription factor complex is tethered to the plasma membrane via a transmembrane domain; and (b) a reporter system comprising (1) a first nucleic acid encoding flippase operably linked to the upstream activating sequence that binds Gal4; and (2) a second nucleic acid comprising an FRT-flanked stop codon cassette separating a constitutive promoter and a fluorescent protein open reading frame.

## Claims

### Claim 1

An in vivo biosensor comprising:
a. a transcription factor complex comprising the Gal4 transcription factor linked to an enzyme cleavable linker, wherein the transcription factor complex is tethered to the plasma membrane via a transmembrane domain; and
b. a reporter system comprising (1) a first nucleic acid encoding flippase operably linked to the upstream activating sequence that binds Gal4; and (2) a second nucleic acid comprising an FRT-flanked stop codon cassette separating a constitutive promoter and a fluorescent protein open reading frame.

### Claim 2 (depends on 1)

The biosensor of claim 1, wherein the enzyme cleavable linker is cleaved by an enzyme specifically expressed during apoptosis.

### Claim 3 (depends on 1)

The biosensor of claim 1, wherein the enzyme is caspase.

### Claim 4 (depends on 1)

The biosensor of claim 1, wherein the fluorescent protein comprises green fluorescent protein, red fluorescent protein, or yellow fluorescent protein.

### Claim 5 (depends on 1)

A transgenic mammal comprising the biosensor of claim 1.

### Claim at position 6

6-9. (canceled)

### Claim 10

A biosensor system comprising:
a. a site-specific recombinase tethered to the plasma membrane of a test cell, wherein the recombinase is linked to a transmembrane domain via an enzyme cleavable linker; and
b. a nucleic acid encoding a reporter gene operably linked to a promoter, wherein the recognition target sequence of the recombinase flanks a stop codon cassette located between the reporter gene and the promoter.

### Claim 11

A biosensor system comprising:
a. a site-specific recombinase tethered to the plasma membrane of a test cell, wherein the recombinase is linked to a transmembrane domain via an enzyme cleavable linker; and
b. a nucleic acid encoding a reporter gene operably linked to a promoter, wherein the recognition target sequence of the recombinase flanks a stop codon cassette located between the reporter gene and the promoter.

### Claim 12 (depends on 11)

The biosensor system of claim 11, wherein the site-specific recombinase is flippase and the recognition target sequence is FRT.

### Claim 13 (depends on 11)

The biosensor system of claim 11, wherein the reporter gene encodes a fluorescent protein.

### Claim 14 (depends on 11)

The biosensor system of claim 11, wherein the promoter is a constitutive promoter.

### Claim 15 (depends on 11)

The biosensor system of claim 11, wherein the enzyme is caspase.

### Claim at position 13

16-19. (canceled)

### Claim 20

A biosensor comprising a nucleic acid comprising a stop codon cassette flanked by site specific recombinase recombination sequences, wherein the stop codon cassette and flanking sequences separate a constitutive promoter and a fluorescent protein open reading frame.

### Claim 21 (depends on 20)

The biosensor of claim 20, wherein the recombinase is a recombinase expressed only during apoptosis.
